Cancer Clinical Trial -Y-mAbs Therapeutics- 1001

Cancer

ClinicalTrials.gov:

NCT05130255

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Drug

GD2-SADA:177Lu-DOTA Complex

Phase

Phase I

Condition

Small Cell Lung, Malignant Melanoma, Sarcoma

Keywords

GD2 Expression